Source: Markets Insider

Plexium: PLEXIUM APPOINTS BRIAN WONG, M.D., PH.D., TO ITS BOARD OF DIRECTORS

SAN DIEGO, July 13, 2022 /PRNewswire/ -- Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today anno...

Read full article »

Plexium's Competitors | Plexium's News | Plexium's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

President & CEO

Michael Martin

CEO Approval Rating

86/100

Plexium is a California-based biotechnology company that develops a platform that provides targeted protein degradation therapies for the treatment of cancer.